Wannarasmi Ketchart

Wannarasmi Ketchart

Auto-generated profile, based on publicly available information

Wannarasmi Ketchart

Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

17 August 2016 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
NSNithidol Sakunrangsit
Nithidol Sakunrangsit
NKNuttiya Kalpongnukul
Nuttiya Kalpongnukul
TPTrairak Pisitkun
Trairak Pisitkun
WKWannarasmi Ketchart
Wannarasmi Ketchart

11 November 2019 in Phytomedicine
Verified
Journal Article
Closed access
PDF file
NPNalinee Pradubyat
Nalinee Pradubyat
NSNithidol Sakunrangsit
Nithidol Sakunrangsit
AMApiwat Mutirangura
Apiwat Mutirangura
WKWannarasmi Ketchart
Wannarasmi Ketchart

1 February 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NSNithidol Sakunrangsit
Nithidol Sakunrangsit
WKWannarasmi Ketchart
Wannarasmi Ketchart

6 October 2019 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
PCPiriya Chonsut
Piriya Chonsut
PMPanupong Mahalapbutr
Panupong Mahalapbutr
NPNalinee Pradubyat
Nalinee Pradubyat
WCWarinthorn Chavasiri
Warinthorn Chavasiri
PWPiyanuch Wonganan
Piyanuch Wonganan
WKWannarasmi Ketchart
Wannarasmi Ketchart

14 January 2021 in Planta Medica
Verified
Journal Article
Closed access
PDF file
NPNalinee Pradubyat
Nalinee Pradubyat
AGAthina Giannoudis
Athina Giannoudis
TETaha Elmetwali
Taha Elmetwali
PMPanupong Mahalapbutr
Panupong Mahalapbutr
CPCarlo Palmieri
Carlo Palmieri
WKWannarasmi Ketchart
Wannarasmi Ketchart
Estrogen receptor-positive breast cancer patients have a good prognosis, but 30% of these patients will experience recurrence due to the development of resistance through various signaling pathways. This study aimed to evaluate the mode of anticancer effects of 1′-acetoxychavicol acetate, which is isolated from the rhizomes of Alpinia galanga in estrogen receptor positive (MCF7) human epidermal growth factor receptor 2-overexpressed (MCF7/HER2), and endocrine-resistant breast cancer cells (MCF7/LCC2 and MCF7/LCC9). 1′-Acetoxychavicol acetate showed antiproliferation in a concentration- and time-dependent fashion and had higher potency in human epidermal growth factor receptor 2-overexpressed cell lines. This was associated with down-regulation of human epidermal growth factor receptor 2, pERK1/2, pAKT, estrogen receptor coactivator, cyclin D1, and MYC proto-oncogene while in vivo and significant reduction in the tumor mass of 1′-acetoxychavicol acetate-treated zebrafish-engrafted breast cancer groups. The anti-invasive effects of 1′-acetoxychavicol acetate were confirmed in vitro by the matrigel invasion assay and with down-regulation of C – X-C chemokine receptor type 4, urokinase plasminogen activator, vascular endothelial growth factor, and basic fibroblast growth factor 2 genes. The down-regulation of urokinase plasminogen activator and fibroblast growth factor 2 proteins was also validated by molecular docking analysis. Moreover, 1′-acetoxychavicol acetate-treated cells exhibited lower expression levels of the anti-apoptotic Bcl-2 and Mcl-1 proteins in addition to enhanced stress-activated kinases/c-Jun N-terminal kinase 1/2 and poly-ADP ribose polymerase cleavage, indicating apoptotic cell induction by 1′-acetoxychavicol acetate. Moreover, 1′-acetoxychavicol acetate had higher potency in human epidermal growth factor receptor 2-overexpressed cell lines regarding its inhibition on human epidermal growth factor receptor 2, pAKT, pERK1/2, PSer118, and PSer167-ERα proteins. Our findings suggest 1′-acetoxychavicol acetate mediates its anti-cancer effects via human epidermal growth factor receptor 2 signaling pathway. Received: 03 July 2020 Accepted after revision: 10 November 2020 Publication Date: 14 January 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany